# BRYNOVIN

NDC: 24338-017
Generic name: Sitagliptin Hydrochloride Oral
Labeler / Manufacturer: Azurity Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: SOLUTION
Routes: ORAL
Marketing started: 20250401

FDA application: NDA219122

## Active ingredients

- SITAGLIPTIN: 25 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"24338-017"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=24338-017
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9468a2f3-3ebe-40bd-a3b4-d78d9eb47e04